 |
 |

A Case of Familial Amyloid Polyneuropathy Homozygous for the Transthyretin Val30Met Gene With Motor-Dominant Sensorimotor Polyneuropathy and Unusual Sural Nerve Pathological Findings
Akira Yoshioka, MD;
Yoko Yamaya, MD;
Shinji Saiki, MD;
Genjiro Hirose, MD;
Kohei Shimazaki, MD;
Masaaki Nakamura, MD;
Yukio Ando, MD
Arch Neurol. 2001;58:1914-1918.
Objective To report a case of familial amyloid
polyneuropathy homozygous for the amyloidogenic transthyretin (ATTR)
Val30Met gene with motor-dominant sensorimotor polyneuropathy
and unusual sural nerve pathological findings.
Methods Mass spectrometry analysis and polymerase chain
reactionrestricting fragment length polymorphism were performed. A
right sural nerve biopsy specimen was obtained for histological
investigation.
Setting Academic medical center.
Results A 56-year-old Japanese man living in a local town
(Nakajima, Japan) in Ishikawa Prefecture, a nonendemic area of type I
familial amyloidotic polyneuropathy, had vitreous amyloidosis,
motor-dominant sensorimotor polyneuropathy, erectile dysfunction, and
urinary incontinence. He had neither orthostatic hypotension nor
indolent diarrhea. Restriction enzyme analysis with EcoT22 I
of amplified DNA and mass spectrometry analysis revealed homozygosity
for ATTR Val30Met. Of 8 family members, 5 were evaluated and
found to be heterozygous for ATTR Val30Met; a family history
found no relative with the similar neurologic disorders. The sural
nerve biopsy specimen showed focal edema and an amyloid deposit in the
subperineural tissue, associated with moderate loss of myelinated and
unmyelinated fibers.
Conclusions In addition to the findings characteristic of
homozygosity for ATTR Val30Met such as vitreous amyloidosis
and relatively less autonomic involvements, this case had the unique
findings of motor-dominant sensorimotor polyneuropathy and unusual
sural nerve biopsy specimen results.
From the Department of Neurology, Kanazawa Medical University, Uchinada
(Drs Yoshioka, Yamaya, Saiki, and Hirose); Department of Internal
Medicine, Hamano Hospital, Nanao City
(Dr Shimazaki); and the
Department of Laboratory Medicine, Kumamoto University School of
Medicine, Kumamoto (Drs Nakamura
and Ando), Japan.
Corresponding author: Akira Yoshioka, MD, Department of Neurology,
Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa
920-0293, Japan (e-mail: a-yos{at}kanazawa-med.ac.jp).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Impact of homozygosity for an amyloidogenic transthyretin mutation on phenotype and long term outcome
Holmgren et al.
J. Med. Genet. 2005;42:953-956.
ABSTRACT
| FULL TEXT
Familial transthyretin-type amyloid polyneuropathy in Japan: Clinical and genetic heterogeneity
Ikeda et al.
Neurology 2002;58:1001-1007.
ABSTRACT
| FULL TEXT
|